These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2826959)

  • 21. Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.
    Petrillo P; La Regina A; Sbacchi M; Tavani A; Robson LE; Kosterlitz HW
    Eur J Pharmacol; 1989 Jul; 166(2):213-7. PubMed ID: 2551699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of opioid binding subtypes in the bovine adrenal medulla.
    Bunn SJ; Marley PD; Livett BG
    Neuroscience; 1988 Dec; 27(3):1081-94. PubMed ID: 2855262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE; Ho BY; Naeseth JS; Portoghese PS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of 3H-tifluadom binding in guinea-pig brain membranes.
    Burkard WP; Müller PM; Flück N
    J Recept Res; 1984; 4(1-6):165-73. PubMed ID: 6151988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC; Pert CB
    Neuropeptides; 1984 Jun; 4(4):311-7. PubMed ID: 6206435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain.
    Pilapil C; Welner S; Magnan J; Gauthier S; Quirion R
    Brain Res Bull; 1987 Nov; 19(5):611-5. PubMed ID: 2825931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
    Tavani A; Gambino MC; Petrillo P
    J Pharm Pharmacol; 1984 May; 36(5):343-4. PubMed ID: 6145777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.
    Schnittler M; Liebmann C; Schrader U; Schulze HP; Neubert K; Repke H
    Biomed Biochim Acta; 1990; 49(4):209-18. PubMed ID: 2169723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice.
    Inoue M; Ueda H
    J Pharmacol Exp Ther; 2000 May; 293(2):662-9. PubMed ID: 10773042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
    Zhang WM; Jin WQ; Wong TM
    J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II.
    Búzás B; Tóth G; Cavagnero S; Hruby VJ; Borsodi A
    Life Sci; 1992; 50(14):PL75-8. PubMed ID: 1313131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of [3H]DAGO1 binding to rat brain by low concentrations of monovalent cations.
    Bolger GT; Marcus KA; Thibou R; Skolnick P; Weissman BA
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2338-45. PubMed ID: 2835135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.